Chemical formula: C₄H₁₃NO₇P₂ Molecular mass: 249.096 g/mol PubChem compound: 2088
Alendronic acid is a bisphosphonate that inhibits osteoclastic bone resorption with no direct effect on bone formation. The bone formed during treatment with alendronic acid is of normal quality.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
ATC code | Group title | Classification |
---|---|---|
M05BA04 | Alendronic acid | M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Title | Information Source | Document Type | |
---|---|---|---|
FOSAMAX Once Weekly Tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Alendronic acid is an active ingredient of these brands:
United States (US)
Albania (AL)
Australia (AU)
Austria (AT)Brazil (BR)
Canada (CA)Croatia (HR)Cyprus (CY)Ecuador (EC)
Estonia (EE)Finland (FI)France (FR)Germany (DE)Hong Kong (HK)
Ireland (IE)
Israel (IL)Italy (IT)
Lithuania (LT)Malta (MT)
Mexico (MX)
Netherlands (NL)New Zealand (NZ)
Nigeria (NG)Poland (PL)Romania (RO)Singapore (SG)
South Africa (ZA)
Spain (ES)Tunisia (TN)
Turkey (TR)
United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.